Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway
Crossref DOI link: https://doi.org/10.1038/aps.2017.102
Published Online: 2017-10-26
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Juan-juan
Yin, Xiao-wei
Liu, Hui-hui
Du, Wen-xiu
Shi, Lu-yao
Huang, Ya-bo
Wang, Fen
Liu, Chun-feng
Cao, Yong-jun
Zhang, Yan-lin
Text and Data Mining valid from 2017-10-26
Article History
Received: 29 March 2017
Accepted: 9 July 2017
First Online: 26 October 2017